iBio (IBIO) EBITDA Margin (QoQ) (2011 - 2025)
iBio (IBIO) EBITDA Margin (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.76 Bn | 131.91 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.51 Bn | 78.51 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.74 Bn | 60.56 Bn | 1.37 Bn |
| 4 | Moderna | 59.39 Bn | 54.26 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.24 Bn | 37.15 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.78 Bn | 28.47 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.65 Bn | 10.26 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.22 Bn | 26.39 Bn | - |
| 10 | iBio | 177.01 Mn | 177.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -335,200.00 |
| Sep 30, 2021 | -429,783.00 |
| Jun 30, 2021 | -98,083.00 |
| Mar 31, 2021 | 12,864.00 |
| Dec 31, 2020 | 61,857.00 |
| Sep 30, 2020 | -142,726.00 |
| Jun 30, 2020 | 397,182.00 |
| Mar 31, 2020 | -322,856.00 |
| Dec 31, 2019 | 256,467.00 |
| Sep 30, 2019 | -305,963.00 |
| Jun 30, 2019 | 20,556.00 |
| Mar 31, 2019 | -9,863.00 |
| Dec 31, 2018 | 816,103.00 |
| Sep 30, 2018 | -444,151.00 |
| Jun 30, 2018 | 14,194.00 |
| Mar 31, 2018 | -223,834.00 |
| Dec 31, 2017 | 51,505.00 |
| Sep 30, 2017 | -12,975.00 |
| Jun 30, 2017 | 801,267.00 |
| Mar 31, 2017 | -620,450.00 |